IMPROVE Time to Anti-Coagulation Reversal for Hemorrhagic Strokes

Author:

Dymm Braydon1ORCID,Graffagnino Carmelo2,Acosta Gabriel Torrealba2,Ehrlich Matthew2,Monk Lisa2,Shah Shreyansh2,Iversen Edwin2,Kolls Brad2ORCID

Affiliation:

1. Charleston Area Medical Center

2. Duke University Hospital

Abstract

Abstract

Background Oral anticoagulation (OAC) is a risk factor for intracerebral hemorrhage (ICH) which is an important source of disability and mortality. OAC-associated ICH (OAC-ICH) patients have worse outcomes as compared to ICH patients not on OAC, likely because of the associated larger stroke volumes, higher propensity to intraventricular hemorrhage, and a higher risk of rebleeding. Although current guidelines recommend that OAC should be reversed quickly, many health care systems have not developed a process for optimizing that aspect of care. Methods Through the IMPROVE Stroke Care Consortium, a group of nine Hub hospitals and their 57 regional community hospitals, a systems of care improvement project was implemented. Performance reviews identified best practices which were disseminated throughout all centers. We compared the median door-to-reversal (DTR) time before and after an institutional campaign to speed the process with a target time of 60 minutes. Results Over two years of the study, there were 6,699 ischemic strokes, 152 subarachnoid hemorrhages, and 889 intracerebral hemorrhages. During that time, 36 hemorrhagic stroke patients received reversal agents emergently. The overall baseline median DTR time was 123 minutes (IQR 99, 361 minutes). By the end of the program, the median DTR time had trended down to 84 minutes (IQR 58.5, 151 minutes) which is a 31.7% reduction of DTR from baseline, though times remained somewhat variable (p = 0.08). Conclusions Utilizing an integrated stroke systems of care approach, we were able to reduce DTR times for patients presenting with acute ICH and concurrent use of anticoagulants despite lack of definitive guidelines around targets for reversal times or operational guidance on protocols and agents.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3